Abstract: The present disclosure is directed to implementation of an environmental control unit using rotomolded techniques to fabricate the structures of the unit instead of the standard conventional sheet metal, extruded, forged, and punched parts. Such implementations will provide a lighter weight and more durable mechanical configuration that will also simplify inspection, simplify assembly/disassembly, and reduce fabrication costs. Implementations incorporate rotationally-molded interlocking structures to contain and attach the critical items of the ECU's mechanical components including the compressor, and the indoor and outdoor coils, as well as the fan and blower motor assembly. In one implementation, the rotomolded structure is strengthened and insulated (thermally and acoustically) by filling the interior void of the rotationally molded structure with a closed-cell foam.

Abstract: A one layer building panel derives its structural integrity from a foam forming the layer that bonds to horizontal and vertical stud members with a mesh material disposed therein. The vertical members can be provided at the edges of the building panel. The horizontal members can be provided at the edges of the building panel and together with the vertical member form a peripheral frame for the building panel. The foam is bonded to the horizontal and vertical stud members using above ambient temperatures and pressures. A mesh can be provided within the foam. A fiber reinforced layer can be provided on the interior and/or exterior surfaces of the foam. Building panels can be connected to one another to construct a building wall and ceiling using stud members having an interlocking capabilities. The building panels can be inserted into tracks secured to a floor using anchors.

Abstract: A one layer building panel derives its structural integrity from a foam forming the layer that bonds to horizontal and vertical stud members with a mesh material disposed therein. The vertical members can be provided at the edges of the building panel. The horizontal members can be provided at the edges of the building panel and together with the vertical member form a peripheral frame for the building panel. The foam is bonded to the horizontal and vertical stud members using above ambient temperatures and pressures. Building panels can be connected to one another to construct a building wall and ceiling using stud members having an interlocking capabilities. The building panels can be inserted into tracks secured to a floor using anchors.

Abstract: A method of manufacturing a single layer building panel. The building panels include a peripheral frame having vertical and horizontal members. One or more surfaces of the building panel can be configured with a fiber reinforced layer. The building panels can be manufactured with electrical components. The building panels can also be manufactured with openings for windows, doors and the like. The interior of the panel can include a mesh material disposed therein.

Abstract: The method of use of danazol for reducing or eliminating urinary incontinence and any associated frequent urination in a person suffering therefrom and pharmaceutical compositions therefor are disclosed.

Abstract: Danazol, a known androgen, is used to (1) correct immune abnormalities associated with hemotologic disorders or (2) treating immune disorders associated with depressed T helper cells, in the invention disclosed.

Abstract: Treatment of sickle cell disease using danazol.

Abstract: Calcium (Ca.sup.2+) channel blockers, such as nifedipine and verapamil, are used in the treatment of thromboembolic diseases such as stroke and peripheral vascular occlusive diseases, especially arterial and venous thrombosis, vasculitis, myelofibrosis disease and hemolytic anemias. Such diseases arise from platelet hyperactivation and the Ca.sup.2+ channel blockers restore the platelets to their normal aggregation characteristics. Diagnostic procedures for detecting platelet hyperactivation and defective calcium handling/transport indicative of certain peripheral obstructive diseases using chlorotetracycline as a detectable fluorescent probe as a means of assessing a patient's response to Ca.sup.2+ channel blockers in the therapy of such diseases are also described.